Trending...
- Matt Stuckert Joins Lineus Medical Board of Directors
- The Right Reverend Mariann Edgar Budde, Bishop of the Episcopal Diocese of Washington, Joins Seabury Resources for Aging® Board of Governors
- Aries Industries Celebrates 40 Years of Innovation, Growth and Service
Webcast scheduled for Monday, July 22 at 8:00 a.m. Eastern Time
CARLSBAD, Calif., July 8, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, July 22nd at 8:00 a.m. Eastern Time to discuss results from the Phase 1/2a HALOS study of ION582 for the treatment of people with Angelman syndrome. Results from the HALOS study will also be presented on Wednesday, July 24 at the 2024 Angelman Syndrome Foundation (ASF) Family Conference and Research Symposium in Sandusky, Ohio.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
More on Ohio Pen
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – [email protected] – 760-603-4679
SOURCE Ionis Pharmaceuticals, Inc.
CARLSBAD, Calif., July 8, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, July 22nd at 8:00 a.m. Eastern Time to discuss results from the Phase 1/2a HALOS study of ION582 for the treatment of people with Angelman syndrome. Results from the HALOS study will also be presented on Wednesday, July 24 at the 2024 Angelman Syndrome Foundation (ASF) Family Conference and Research Symposium in Sandusky, Ohio.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
More on Ohio Pen
- Announcing The Must-Read Crypto Playbook Of 2025!
- Countdown of Cuteness: CFA Reveals the Top 10 Pedigree at Breeds for 2025!
- Etan Polinger Officially Recognized As New Mexico's First Certified Ai Consultant
- Expert Law Attorneys Nominates 2025 Personal Injury Firms
- The Ripple Effect Arts Leverages Social Media to Showcase the Benefits of Magic Magnesium Spray, Driving 200% Audience Growth
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – [email protected] – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – [email protected] – 760-603-4679
SOURCE Ionis Pharmaceuticals, Inc.
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Pan-Armenian Digital Trade Center Launched on Fastexverse
- Stern Recruiting Launches with a Mission to Revolutionize Talent Acquisition
- Bonita Mitchell Releases Inspiring Single "Let This Mind Be In Me" From Book Soundtrack 'The First Lady'
- ASI Holds Annual Executive Business Summit Showcasing Suite of Solutions & Celebrates 2024 Partner Award Winners
- Webinar Announcement: Collaborating for Digital Transformation: Innovation, Governance, and the Future of Financial Operations
- Veterans for America First condemns a faith-based smear campaign against Muslim Candidate Sophia Farooq in Cobb County Georgia as Integrity Matters
- Jarrett Supply Chain Summit Returns to Ohio Aug. 7 Featuring VIP Dinner with NFL Legend Cris Carter
- Wags Bakery Launches Snack Pack Dog Treats on Amazon
- Nigeria is next biggest crypto-mining country - Oneminers is investing millions
- Corcoran DeRonja Real Estate Welcomes Mechelle Fuquay as Its Newest Broker
- Matt Stuckert Joins Lineus Medical Board of Directors
- Marco's Pizza Rolls Out Franchise Development Incentive Program with 0% Royalties to Start*
- Fray Fitness Launches Redesigned Website to Enhance Customer Experience
- Rampage Jackson and Rashad Evans Face Off At Press Conference At The Palms Casino Resort in Las Vegas on March 20, 2025
- Loudon Ford's GM at Ford's Intensive Dealer Seminar in Michigan
- Drone Light Shows Become the Must-Have Entertainment Trend for Events and Venues
- A Cost-Effective Solution For Predictive Maintenance
- Multi-Million Dollar Contracts and Key Partnerships for Cybersecurity Solutions in the Rapidly Growing Market Nearing $200 Billion Annually $CYCU
- Unveil Hydrogen-Powered Maritime Innovation at H2Hub Summit
- 123Invent Inventor Develops New Miniature Garden Fork (OSK-1147)